Skip to main content

Table 2 Overall response of target lesions according to RECIST v1.0 by DL

From: External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26

 

Overall

DL 1

(54Gy)

DL 2

(58Gy)

DL 3

(62Gy)

Best response (N)

18

6

6

6

 PR

10 (56%)

4 (67%)

4 (67%)

2 (33%)

 SD

5 (28%)

2 (33%)

2 (33%)

1 (17%)

 NA

3 (17%)

  

3 (50%)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us